Robin Scott Gray
Examiner (ID: 11474)
Most Active Art Unit | 1307 |
Art Unit(s) | 1307, 1773, 1732 |
Total Applications | 176 |
Issued Applications | 83 |
Pending Applications | 18 |
Abandoned Applications | 75 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18144143
[patent_doc_number] => 20230017994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => COMPOSITIONS AND USES OF LOCALLY-APPLIED ANTIMICROBIAL SYNTHETIC CATIONIC POLYPEPTIDE(S) WITH ENHANCED PERFORMANCE AND SAFETY
[patent_app_type] => utility
[patent_app_number] => 17/654021
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17654021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/654021 | COMPOSITIONS AND USES OF LOCALLY-APPLIED ANTIMICROBIAL SYNTHETIC CATIONIC POLYPEPTIDE(S) WITH ENHANCED PERFORMANCE AND SAFETY | Mar 7, 2022 | Pending |
Array
(
[id] => 17836403
[patent_doc_number] => 20220273708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => FIBROUS CONSTRUCTS WITH THERAPEUTIC MATERIAL PARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/652552
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17652552
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/652552 | FIBROUS CONSTRUCTS WITH THERAPEUTIC MATERIAL PARTICLES | Feb 24, 2022 | Pending |
Array
(
[id] => 17655361
[patent_doc_number] => 20220175826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => SOLID PREPARATION, METHOD FOR PRODUCING SOLID PREPARATION, AND METHOD FOR GENERATING HYDROGEN
[patent_app_type] => utility
[patent_app_number] => 17/679973
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679973 | Solid preparation, method for producing solid preparation, and method for generating hydrogen | Feb 23, 2022 | Issued |
Array
(
[id] => 18565569
[patent_doc_number] => 20230255896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHOD AND SYSTEM FOR MANUFACTURING ORAL SOLUBLE FILMS, COMPOSITIONS OF ORAL SOLUBLE FILMS, ORAL SOLUBLE FILMS MADE BY THEREBY, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/015422
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015422
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015422 | METHOD AND SYSTEM FOR MANUFACTURING ORAL SOLUBLE FILMS, COMPOSITIONS OF ORAL SOLUBLE FILMS, ORAL SOLUBLE FILMS MADE BY THEREBY, AND METHODS OF USE THEREOF | Feb 17, 2022 | Pending |
Array
(
[id] => 17792205
[patent_doc_number] => 20220251296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/672341
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672341
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672341 | Polymer excipients for drug delivery applications | Feb 14, 2022 | Issued |
Array
(
[id] => 18978838
[patent_doc_number] => 11903992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Composition comprising lidocaine, l-carnosine and dexpanthenol
[patent_app_type] => utility
[patent_app_number] => 17/650664
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17778
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650664 | Composition comprising lidocaine, l-carnosine and dexpanthenol | Feb 9, 2022 | Issued |
Array
(
[id] => 17881025
[patent_doc_number] => 20220296502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => NON-AQUEOUS PATCH
[patent_app_type] => utility
[patent_app_number] => 17/667010
[patent_app_country] => US
[patent_app_date] => 2022-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667010
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667010 | Non-aqueous patch | Feb 7, 2022 | Issued |
Array
(
[id] => 18517686
[patent_doc_number] => 11707557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof
[patent_app_type] => utility
[patent_app_number] => 17/591806
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 58
[patent_no_of_words] => 22792
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591806 | Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof | Feb 2, 2022 | Issued |
Array
(
[id] => 17988927
[patent_doc_number] => 20220354964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => HYDROGEL PRODRUG FOR TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/591182
[patent_app_country] => US
[patent_app_date] => 2022-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591182
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591182 | Hydrogel prodrug for treatment | Feb 1, 2022 | Issued |
Array
(
[id] => 17702605
[patent_doc_number] => 20220202611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => TEAR TRANSPLANTATION AND MULTI-PART CONTACT LENS WITH ABSORBENT PORTION
[patent_app_type] => utility
[patent_app_number] => 17/579682
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579682
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579682 | TEAR TRANSPLANTATION AND MULTI-PART CONTACT LENS WITH ABSORBENT PORTION | Jan 19, 2022 | Abandoned |
Array
(
[id] => 17561844
[patent_doc_number] => 20220125993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => Cardiovascular Prostheses
[patent_app_type] => utility
[patent_app_number] => 17/572199
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572199 | Cardiovascular Prostheses | Jan 9, 2022 | Pending |
Array
(
[id] => 17561845
[patent_doc_number] => 20220125994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => Cardiovascular Prostheses
[patent_app_type] => utility
[patent_app_number] => 17/572258
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572258 | Cardiovascular Prostheses | Jan 9, 2022 | Pending |
Array
(
[id] => 18836805
[patent_doc_number] => 11844862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Treatment of ocular conditions utilizing a histone/protein deacetylase inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/571197
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7539
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571197
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/571197 | Treatment of ocular conditions utilizing a histone/protein deacetylase inhibitor | Jan 6, 2022 | Issued |
Array
(
[id] => 17532298
[patent_doc_number] => 20220110907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE
[patent_app_type] => utility
[patent_app_number] => 17/560902
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560902
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/560902 | COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE | Dec 22, 2021 | Pending |
Array
(
[id] => 17503272
[patent_doc_number] => 20220096374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHOD AND COMPOSITION FOR MAKING AN ORAL SOLUBLE FILM, CONTAINING AT LEAST ONE ACTIVE AGENT
[patent_app_type] => utility
[patent_app_number] => 17/550135
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17550135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/550135 | METHOD AND COMPOSITION FOR MAKING AN ORAL SOLUBLE FILM, CONTAINING AT LEAST ONE ACTIVE AGENT | Dec 13, 2021 | Pending |
Array
(
[id] => 17519192
[patent_doc_number] => 20220105040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => MULTI-PARTICULATE PHARMACEUTICAL COMPOSITION OF QUETIAPINE
[patent_app_type] => utility
[patent_app_number] => 17/550785
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17550785
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/550785 | Multi-particulate pharmaceutical composition of quetiapine | Dec 13, 2021 | Issued |
Array
(
[id] => 17988828
[patent_doc_number] => 20220354865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
[patent_app_type] => utility
[patent_app_number] => 17/457882
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17457882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/457882 | PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT | Dec 5, 2021 | Abandoned |
Array
(
[id] => 17472375
[patent_doc_number] => 20220079879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => EMULSIFIED GEL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/536295
[patent_app_country] => US
[patent_app_date] => 2021-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17536295
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/536295 | Emulsified gel composition | Nov 28, 2021 | Issued |
Array
(
[id] => 17586453
[patent_doc_number] => 11324694
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-10
[patent_title] => Nebulization formulations for delivery to lower respiratory tract
[patent_app_type] => utility
[patent_app_number] => 17/513759
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8040
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513759
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/513759 | Nebulization formulations for delivery to lower respiratory tract | Oct 27, 2021 | Issued |
Array
(
[id] => 18558621
[patent_doc_number] => 11723845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Cosmetic compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/465574
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 16501
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465574
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465574 | Cosmetic compositions and uses thereof | Sep 1, 2021 | Issued |